These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18269360)

  • 1. Intranasal naloxone for the treatment of suspected heroin overdose.
    Kerr D; Dietze P; Kelly AM
    Addiction; 2008 Mar; 103(3):379-86. PubMed ID: 18269360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
    Kerr D; Kelly AM; Dietze P; Jolley D; Barger B
    Addiction; 2009 Dec; 104(12):2067-74. PubMed ID: 19922572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.
    Barton ED; Colwell CB; Wolfe T; Fosnocht D; Gravitz C; Bryan T; Dunn W; Benson J; Bailey J
    J Emerg Med; 2005 Oct; 29(3):265-71. PubMed ID: 16183444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Take-home naloxone to reduce heroin death.
    Baca CT; Grant KJ
    Addiction; 2005 Dec; 100(12):1823-31. PubMed ID: 16367983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.
    Robertson TM; Hendey GW; Stroh G; Shalit M
    Prehosp Emerg Care; 2009; 13(4):512-5. PubMed ID: 19731165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.
    Cantwell K; Dietze P; Flander L
    Resuscitation; 2005 Jun; 65(3):315-9. PubMed ID: 15919568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose.
    Wampler DA; Molina DK; McManus J; Laws P; Manifold CA
    Prehosp Emerg Care; 2011; 15(3):320-4. PubMed ID: 21612385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment.
    Mégarbane B; Buisine A; Jacobs F; Résière D; Chevillard L; Vicaut E; Baud FJ
    J Subst Abuse Treat; 2010 Jun; 38(4):403-7. PubMed ID: 20189341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Training and prescription of naloxone for personal use in overdose for opiate addicts.
    Barrie J
    Emerg Med J; 2008 Oct; 25(10):688-9. PubMed ID: 18843073
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses.
    Merlin MA; Saybolt M; Kapitanyan R; Alter SM; Jeges J; Liu J; Calabrese S; Rynn KO; Perritt R; Pryor PW
    Am J Emerg Med; 2010 Mar; 28(3):296-303. PubMed ID: 20223386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose?
    Weber JM; Tataris KL; Hoffman JD; Aks SE; Mycyk MB
    Prehosp Emerg Care; 2012; 16(2):289-92. PubMed ID: 22191727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heroin addicts to receive CPR training and Narcan.
    Lindstrom AM
    JEMS; 2003 May; 28(5):142-4. PubMed ID: 12774790
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients.
    Boyd JJ; Kuisma MJ; Alaspää AO; Vuori E; Repo JV; Randell TT
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1266-70. PubMed ID: 17067327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 15. The distribution of naloxone to heroin users.
    Darke S; Hall W
    Addiction; 1997 Sep; 92(9):1195-9. PubMed ID: 9374020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case for peer naloxone further strengthened.
    Lenton S
    Addiction; 2008 Oct; 103(10):1658-9. PubMed ID: 18821876
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.
    Brewer C
    BMJ; 2006 Oct; 333(7571):754-5. PubMed ID: 17023477
    [No Abstract]   [Full Text] [Related]  

  • 18. Do heroin overdose patients require observation after receiving naloxone?
    Willman MW; Liss DB; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment.
    Stam NC; Pilgrim JL; Drummer OH; Smith K; Gerostamoulos D
    Clin Toxicol (Phila); 2018 Nov; 56(11):1135-1142. PubMed ID: 29873588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.